Swiss All Share Index
17.704,72
PKT
-266,25
PKT
-1,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.01.19 | Givaudan Hold | Kepler Cheuvreux | |
| 25.01.19 | Givaudan Underweight | Barclays Capital | |
| 25.01.19 | UBS buy | HSBC | |
| 25.01.19 | Givaudan Underperform | Bernstein Research | |
| 25.01.19 | Givaudan Neutral | UBS AG | |
| 25.01.19 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 24.01.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 24.01.19 | UBS Hold | Deutsche Bank AG | |
| 24.01.19 | UBS Reduce | Kepler Cheuvreux | |
| 24.01.19 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.01.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.01.19 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.01.19 | Holcim Sell | UBS AG | |
| 23.01.19 | Logitech Hold | Maxim Group | |
| 23.01.19 | Zurich Insurance Hold | Deutsche Bank AG | |
| 23.01.19 | Nestlé buy | Deutsche Bank AG | |
| 23.01.19 | UBS Sector Perform | RBC Capital Markets | |
| 23.01.19 | UBS overweight | JP Morgan Chase & Co. | |
| 23.01.19 | Swiss Re buy | HSBC | |
| 23.01.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 22.01.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 22.01.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 22.01.19 | UBS overweight | Morgan Stanley | |
| 22.01.19 | UBS buy | Baader Bank | |
| 22.01.19 | UBS Sector Perform | RBC Capital Markets | |
| 22.01.19 | UBS Underweight | Barclays Capital | |
| 22.01.19 | UBS Hold | Deutsche Bank AG | |
| 21.01.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 21.01.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 21.01.19 | UBS buy | Goldman Sachs Group Inc. | |
| 18.01.19 | UBS Outperform | Credit Suisse Group | |
| 18.01.19 | ams-OSRAM Neutral | UBS AG | |
| 18.01.19 | Novartis Neutral | UBS AG | |
| 18.01.19 | Roche overweight | JP Morgan Chase & Co. | |
| 17.01.19 | UBS buy | UBS AG | |
| 17.01.19 | UBS buy | HSBC | |
| 17.01.19 | ams-OSRAM overweight | Barclays Capital | |
| 17.01.19 | UBS neutral | Barclays Capital | |
| 16.01.19 | Novartis Underweight | Barclays Capital | |
| 16.01.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. |